Design and Preclinical Evaluation of a Nanoparticle Vaccine against Respiratory Syncytial Virus Based on the Attachment Protein G

Design and Preclinical Evaluation of a Nanoparticle Vaccine against Respiratory Syncytial Virus Based on the Attachment Protein G

Human respiratory syncytial virus (RSV) poses a significant human health threat, particularly to infants and the elderly. While efficacious vaccines based on the F protein have recently received market authorization, uncertainties remain regarding the future need for vaccine updates to counteract po...

Full description

Bibliographic Details
Main Authors: Richard Voorzaat, Freek Cox, Daan van Overveld, Lam Le, Lisanne Tettero, Joost Vaneman, Mark J. G. Bakkers, Johannes P. M. Langedijk
Format: Article
Language:English
Published: MDPI AG 2024-03-01
Series:Vaccines
Subjects:
RSV
lumazine synthase
attachment protein G
nanoparticle
vaccine
Online Access:https://www.mdpi.com/2076-393X/12/3/294

Internet

https://www.mdpi.com/2076-393X/12/3/294

Similar Items